Matthias Schwab (pharmacologist)

Matthias Schwab is a German physician and pharmacologist specializing in clinical pharmacology, personalized medicine, and pharmacogenomics. He is recognized for his research on the genetic basis of drug response variability, particularly in the areas of cancer therapy and transplantation.

Schwab's work has focused on identifying genetic variants that influence drug metabolism, transport, and target interactions, leading to individualized drug dosing and treatment strategies. He has contributed significantly to understanding the role of cytochrome P450 enzymes (CYPs) and other drug-metabolizing enzymes in determining drug efficacy and toxicity.

He has held professorships and leadership positions at various institutions, including the Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology in Stuttgart, Germany, which is affiliated with the University of Tübingen. He has been involved in numerous research projects aimed at translating pharmacogenomic findings into clinical practice.

Schwab has authored and co-authored numerous peer-reviewed publications in scientific journals and has been involved in developing clinical guidelines for pharmacogenomic testing and its application in patient care. He is considered a leading expert in the field of pharmacogenomics and personalized medicine.